Event Specialty: Bronchoscopy
Auris’ Monarch Platform, in collaboration with design and innovation firm Fjord, was named a finalist for the Innovation Award at South by Southwest (SXSW) 2019 in the Health, Med, & BioTech category.
Auris and Fjord joined together to host a tabletop display at the Austin, TX conference this year. According to its website, the SXSW conference and festivals “celebrate the convergence of the interactive, film, and music industries.” The event has sessions, showcases, screenings, exhibitions, and networking opportunities that people can attend.
Auris worked with Fjord’s connected products team to design the Monarch Platform, a flexible endoscopic system designed to help physicians diagnose lung disease that is difficult to reach. The platform provides physicians with access and precision when driving a scope to hard-to-reach nodules in the periphery of the lungs. The Monarch Platform includes a Monarch tower, cart, physician controller, and an instinctive physical and digital user interface. The interface combines traditional endoscopic views with computer-assisted navigation guided by 3D models of the patient’s lungs.
In helping to design the platform, Fjord drew on their experience in industrial and manufacturing design, user experience, user interface, visual design, and high-fidelity prototyping. Fjord also considered the needs of both patients and medical professionals when designing the Monarch Platform. Fjord’s design, combined with Auris’ robotic technology, resulted in a platform that could have a significant impact on diagnosis and treatment of lung disease.
Auris is proud to share its recognition as a finalist for the Innovation Award with Fjord and looks forward to sharing this space with other innovative companies in the healthcare and biotech space.Learn more about Auris’ collaboration with Fjord
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.